Sharma Neeraj, Ahmed Safia
Graded Specialist (Respiratory Medicine), Command Hospital (Eastern Command), Kolkata, India.
Associate Professor (Respiratory Medicine), Command Hospital (Air Force), Bengaluru, India.
Med J Armed Forces India. 2022 Apr;78(2):151-156. doi: 10.1016/j.mjafi.2020.06.010. Epub 2020 Aug 15.
Pulmonary impairment after tuberculosis treatment is seen in 40%-75% of patients despite bacteriological cure. Study aimed to find prevalence of structural and functional pulmonary impairment in a group of previously fit serving soldiers at the end of supervised institutional treatment for pulmonary tuberculosis.
Descriptive cross-sectional study was conducted in a tertiary care center on 375 newly diagnosed patients of pulmonary tuberculosis completed treatment. They underwent spirometry and chest X ray (CXR) at end of treatment. Their lung function was classified as normal or abnormal (obstructive, restrictive, or mixed pattern). Chest radiographs were reported as normal/abnormal. Logistic regression models were used to explore the factors associated with abnormal lung function.
Functional impairment was present in 145/375 (38.7%). 115/375 (30.66%) had restrictive, 24/375 (6.4%) had mixed, and 6/375 (1.6%) had obstructive pattern on spirometry, respectively. Out of the 115 patients having restrictive pattern, 103 (89.56%) had mild restriction, 11(9.56%) had moderate restriction, and 1 (0.86%) had severe restriction. Structural impairment on CXR was present in 309/375 (82.4%) of patients. Significant factors associated with pulmonary impairment in our study were time to diagnosis (>1 month) adj odds ratio (OR) = 1.71, 95% confidence interval (CI) 1.07-2.74, sputum conversion of >2 months, Adj OR 2.52, 95% CI 1.25-5.07, and sputum/culture positivity Adj OR 1.57, 95% CI 1.02-2.42. CXR abnormality was significantly associated with sputum and/culture positivity Adj OR 4.54, 95% CI 2.28-9.03.
Despite successful treatment, pulmonary impairment was present in 38.7% of patients, and structural changes evident on CXR was present in 82.4% of patients.
尽管细菌学治愈,但40%-75%的患者在结核病治疗后仍出现肺部损害。本研究旨在确定一组既往健康的在职军人在接受肺结核监督机构治疗结束时结构和功能性肺部损害的患病率。
在一家三级医疗中心对375例新诊断的已完成治疗的肺结核患者进行描述性横断面研究。他们在治疗结束时接受了肺活量测定和胸部X线检查(CXR)。他们的肺功能被分类为正常或异常(阻塞性、限制性或混合性模式)。胸部X线片报告为正常/异常。使用逻辑回归模型探讨与肺功能异常相关的因素。
145/375(38.7%)存在功能损害。肺活量测定显示,115/375(30.66%)为限制性,24/375(6.4%)为混合性,6/375(1.6%)为阻塞性模式。在115例限制性模式患者中,103例(89.56%)为轻度受限,11例(9.56%)为中度受限,1例(0.86%)为重度受限。309/375(82.4%)的患者CXR存在结构损害。本研究中与肺部损害相关的显著因素为诊断时间(>1个月),调整后的优势比(OR)=1.71,95%置信区间(CI)1.07-2.74,痰菌转阴时间>2个月,调整后的OR 2.52,95%CI 1.25-5.07,以及痰/培养阳性,调整后的OR 1.57,95%CI 1.02-2.42。CXR异常与痰菌和/或培养阳性显著相关,调整后的OR 4.54,95%CI 2.28-9.03。
尽管治疗成功,但38.7%的患者存在肺部损害,82.4% 的患者CXR显示有明显的结构改变。